Schedule 13G ownership disclosure
Aegerion Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00767E102
Event date: 2016-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-16-016725
- Form type
- SC 13G
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Nov 16, 2016
- Reporting period
- Nov 07, 2016
- Description
- Schedule 13G beneficial ownership